pharma
Gedeon Richter Australia
Gedeon Richter Australia Pty Ltd
Gedeon Richter Australia is a pharma organization headquartered in AU. NovaPharmaNews links 1 clinical program(s), 1 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and US
North Sydney, AU HQ
27 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- North Sydney, AU
- Employees
- 27
- Programs
- 1
- Drugs
- 5
- Patents
- 0
Terrosa 20 micrograms/80 microliters solution...
Approved · small molecule · Prevention of new morphometric vertebral fractures and/or worsening of previous vertebral fractures.
Terrosa 20 micrograms/80 microliters solution... for Prevention of new morphometric vertebral fractures and/or worsening of previous vertebral fractures. is a Approved program (small_molecule) at Gedeon Richter Australia Pty Ltd with 1 ClinicalTrials.gov record(s).
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Gedeon Richter Australia Pty Ltd
- Phase
- Approved
- Modality
- small_molecule
- Indication
- Prevention of new morphometric vertebral fractures and/or worsening of previous vertebral fractures.
- Status
- active
- Trials
- 1